| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $408.3M | +26.2% |
| R&D Expense | $76.4M | +13.9% |
| SG&A Expense | $79.7M | +0.6% |
| Operating Income | $15.2M | +145.9% |
| Interest Expense | $9.1M | -52.9% |
| Pre-tax Income | $13.1M | +123.4% |
| Income Tax | -$2.3M | +35.3% |
| Net Income | $15.4M | +129.3% |
| EPS (Basic) | $0.10 | +127.0% |
| EPS (Diluted) | $0.10 | +127.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $86.9M | +18.7% |
| Accounts Receivable | $67.9M | +28.0% |
| Current Assets | $221.1M | +30.0% |
| Total Assets | $1.17B | +3.5% |
| Current Liabilities | $67.8M | +20.0% |
| Long-term Debt | $225.0M | -8.2% |
| Total Liabilities | $360.5M | -0.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $72.5M | +14.0% |
| Capital Expenditures | $2.0M | +111.1% |
| Investing Cash Flow | -$18.3M | +90.9% |
| Financing Cash Flow | -$37.5M | -123.4% |
| Free Cash Flow | $70.5M | +12.5% |
| Stockholders' Equity |
| $808.2M |
| +5.3% |